Alcon Canada Inc. et al. v. Apotex Inc. et al., (2014) 459 F.T.R. 255 (FC)

This document cites

• Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., (2008) 381 N.R. 125 (SCC)
• AstraZeneca Canada Inc. et al. v. Mylan Pharmaceuticals ULC et al., (2012) 432 N.R. 292 (FCA)
• Allergan Inc. et al. v. Canada (Minister of Health) et al., (2012) 440 N.R. 269 (FCA)
• Fournier Pharma Inc. et al. v. Canada (Minister of Health) et al., (2012) 413 F.T.R. 277 (FC)
• Allergan Inc. et al. v. Canada (Minister of Health) et al., (2012) 414 F.T.R. 56 (FC)



See all quotations

• Silver's Garage Ltd. v. Bridgewater (Town), (1970) 2 N.S.R.(2d) 474 (SCC)
• Ruddell v. BC Rail Ltd., (2007) 381 N.R. 399 (Motion)
• Pfizer Canada Inc. et al. v. Canada (Minister of Health) et al., (2007) 366 N.R. 347 (FCA)
• Abbott Laboratories et al. v. Canada (Minister of Health) et al., 2009 FCA 94
• Free World Trust v. Électro Santé Inc. et al., (2000) 263 N.R. 150 (SCC)
• Pfizer Canada Inc. et al. v. Canada (Minister of Health) et al., (2006) 351 N.R. 189 (FCA)
• Apotex Inc. v. Sanofi-Aventis, (2013) 447 N.R. 313 (FCA)
• Beloit Canada Ltd. v. Valmet Oy, (1986) 64 N.R. 287 (FCA)
• Pfizer Canada Inc. et al. v. Mylan Pharmaceuticals ULC et al., (2014) 446 F.T.R. 274 (FC)
• Merck & Co. et al. v. Canada (Minister of Health) et al., 2010 FC 1042
• Pfizer Canada Inc. et al. v. Pharmascience Inc. et al., (2013) 427 F.T.R. 6 (FC)
• Schering-Plough Canada Inc. et al. v. Pharmascience Inc. et al., 2009 FC 1128
• Pfizer Canada Inc. et al. v. Apotex Inc. et al., 2007 FC 26
• BESTE v. Can. (A.G.), [2007] N.R. Uned. 201 (FCA)
• AstraZeneca Canada Inc. et al. v. Mylan Pharmaceuticals ULC et al., 2011 FC 1023
• Alcon Canada Inc. et al. v. Cobalt Pharmaceuticals Co. et al., (2014) 448 F.T.R. 96 (FC)
• AstraZeneca Canada Inc. et al. v. Apotex Inc. et al., 2010 FC 714
• Abbott Laboratories et al. v. Canada (Minister of Health) et al., (2007) 361 N.R. 308 (FCA)
• Hoffman-La Roche Ltd. v. Apotex Inc. et al., (2013) 436 F.T.R. 198 (FC)
• Lundbeck Canada Inc. v. Canada (Minister of Health) et al., (2009) 343 F.T.R. 53 (FC)
• Apotex Inc. and Novopharm Ltd. v. Wellcome Foundation Ltd., (2002) 296 N.R. 130 (SCC)
• Abbott Laboratories et al. v. Canada (Minister of Health) et al., 2008 FC 1359
• Apotex Inc. v. Sanofi-Aventis, (2011) 402 F.T.R. 1 (FC)
• ratiopharm inc. v. Pfizer Ltd., 2010 FCA 204
• Eli Lilly Canada Inc. v. Novopharm Ltd. et al., (2009) 346 F.T.R. 42 (FC)
• Consolboard Inc. v. MacMillan Bloedel (Saskatchewan) Ltd., (1981) 35 N.R. 390 (SCC)
• Lundbeck Canada Inc. et al. v. ratiopharm Inc. et al., (2009) 357 F.T.R. 75 (FC)
• Eli Lilly Canada Inc. et al. v. Novopharm Ltd., (2010) 405 N.R. 1 (FCA)
• Merck & Co. et al. v. Pharmascience Inc. et al., (2010) 368 F.T.R. 1 (FC)
• Pfizer Canada Inc. et al. v. Apotex Inc. et al., 2007 FCA 195